Jason Schulz - 01 Apr 2024 Form 4 Insider Report for GoHealth, Inc. (GOCO)

Role
Chief Financial Officer
Signature
/s/ Bradley Burd, Attorney-in-fact
Issuer symbol
GOCO
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
03 Apr 2024, 21:08:08 UTC
Previous filing
17 May 2023
Next filing
12 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOCO Class A Common Stock Award $0 +33,333 +12% $0.000000 308,847 01 Apr 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOCO Stock Option (Right to Buy) Award $0 +16,667 $0.000000 16,667 01 Apr 2024 Class A Common Stock 16,667 $10.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in three annual installments, with the first such annual installment vesting on April 1, 2025.
F2 Includes 1,421 shares and 545 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023 and December 31, 2023, respectively.
F3 The stock options vest in three annual installments, with the first such annual installment vesting on April 1, 2025.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney